If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

The American Heart Association issued a scientific statement on the role of physical activity in obesity treatment and cardiometabolic health.

A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated ...

According to the latest market analysis by Future Market Insights, the global B-Cell Depletion Therapy Market is projected to ...

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...

Will we finally leave the past behind and make progress on prevention?

Diversifying healthcare financing is essential as Vietnam's system evolves, AstraZeneca Vietnam's chairman tells VIR.

Periodontitis remains a major global health challenge, but better outcomes depend on consensus in diagnosis, collaboration ...

The hyperspecialization of modern medicine partitions patients into isolated organs, driving up systemic costs, and leaving ...